Carl LeBel, Chief Development Officer at Frequency Therapeutics, Inc. (FREQ), sold 1,732 shares at $4.19 ($7K) on 2022-02-17, disclosed to the SEC on 2022-02-18.
Open-market sale of $7k FREQ by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.43 | 831 | $4K | 49.4% |
| 2 | $4.19 | 901 | $4K | 50.6% |
| Total | $4.31 avg | 1,732 | $7K | 100% |
| Filing → |
| FREQ | SELL | 2022-02-16 | $4K | — | Filing → |
| OTIC | SELL | 2016-11-22 | $384K | — | Filing → |
| OTIC | SELL | 2016-09-08 | $381K | — | Filing → |